Momentum Indicators: RSI, MACD & Overbought/Oversold Status Currently, the Relative Strength Index (RSI) for CTNM stands at 54.416, which suggests a Neutral condition. Meanwhile, the MACD (12, 26) indicator is at 0.652, providing a Buy signal for short-term momentum. Other oscillators like the Stochastic Oscillator at 60.106 and the Commodity Channel Index (CCI) at -40.138 further confirm a 0.6 outlook for the stock.

Support, Resistance & Moving Averages From a structural perspective, CTNM is trading above its 60-day moving average of $12.937 and above its 200-day long-term moving average of $9.587. Key price levels to watch include the immediate resistance at $16.527 and strong support at $14.277. A break above $16.527 could signal a bull continuation, while falling below $14.277 may test the next Fibonacci floor at $13.053.

Contineum Therapeutics Inc (CTNM) Support & Resistance Level

Name	S3	S2	S1	Pivot Points	R1	R2	R3
Classic	12.027	13.053	14.277	15.303	16.527	17.553	18.777
Fibonacci	13.053	13.913	14.444	15.303	16.163	16.694	17.553

Contineum Therapeutics Inc (CTNM) Technical Indicators

2026-03-02

Name	Value
RSI_14	54.416
STOCHk_14_3_3	60.106
STOCHd_14_3_3	70.553
CCI_20	-40.138
AO_5_34	1.519
MOM_10	0.6
MACD_12_26_9	0.652

Contineum Therapeutics Inc (CTNM) Relative Strength Index (RSI) is 54.416, creating a Neutral signal.

Contineum Therapeutics Inc (CTNM) Stochastic Oscillator is 60.106, creating a Neutral signal.

Contineum Therapeutics Inc (CTNM) Stochastic RSI is 70.553, creating a Neutral signal.

Contineum Therapeutics Inc (CTNM) Commodity Channel Index (CCI) is -40.138, creating a Neutral signal.

Contineum Therapeutics Inc (CTNM) Awesome Oscillator is 1.519, creating a Buy signal.

Contineum Therapeutics Inc (CTNM) Momentum is 0.6, creating a Buy signal.

Contineum Therapeutics Inc (CTNM) MACD is 0.652, creating a Buy signal.

Contineum Therapeutics Inc (CTNM) Moving Average

2026-03-02

Period	Simple	Signal
MA_5	15.574	Sell
MA_10	15.5	Sell
MA_20	15.223	Sell
MA_60	12.937	Buy
MA_200	9.587	Buy
MA_250	8.788	Buy

Contineum Therapeutics Inc (CTNM) 5-Day simple moving average is 15.574, while Contineum Therapeutics Inc (CTNM) share price is $15.135, making it a Sell.

Contineum Therapeutics Inc (CTNM) 10-Day simple moving average is 15.5, while Contineum Therapeutics Inc (CTNM) share price is $15.135, making it a Sell.

Contineum Therapeutics Inc (CTNM) 20-Day simple moving average is 15.223, while Contineum Therapeutics Inc (CTNM) share price is $15.135, making it a Sell.

Contineum Therapeutics Inc (CTNM) 60-Day simple moving average is 12.937, while Contineum Therapeutics Inc (CTNM) share price is $15.135, making it a Buy.

Contineum Therapeutics Inc (CTNM) 200-Day simple moving average is 9.587, while Contineum Therapeutics Inc (CTNM) share price is $15.135, making it a Buy.

Contineum Therapeutics Inc (CTNM) 250-Day simple moving average is 8.788, while Contineum Therapeutics Inc (CTNM) share price is $15.135, making it a Buy.

People Also Watch

Frequently Asked Questions

What is the current technical consensus for CTNM?

The overall technical consensus for Contineum Therapeutics Inc (CTNM) is currently Buy. This rating is derived from a combined analysis of moving averages and oscillators, currently showing 4 buy signals and 1 sell signals.

What are the key support and resistance levels for Contineum Therapeutics Inc (CTNM) today?

Based on pivot point calculations, Contineum Therapeutics Inc (CTNM) has an immediate support level at 14.277 and a major resistance level at 16.527. Traders also monitor the pivot point at 15.303 to determine the intraday trend direction.

Is Contineum Therapeutics Inc (CTNM) overbought or oversold based on the RSI?

The Relative Strength Index (RSI) for Contineum Therapeutics Inc (CTNM) is currently 54.416. This indicates that the stock is in neutral territory (typically, a value below 30 is oversold and above 70 is overbought).

What signal is the MACD providing for Contineum Therapeutics Inc (CTNM)?

Contineum Therapeutics Inc (CTNM) Moving Averages Convergence Divergence (MACD) indicator is 0.652, suggesting CTNM is Buy. This indicator helps identify potential trend reversals or momentum shifts for Contineum Therapeutics Inc.

How is Contineum Therapeutics Inc (CTNM) performing relative to its 200-day moving average?

Contineum Therapeutics Inc (CTNM) is currently trading at $15.135, which is above its 200-day simple moving average of 9.587. Trading above the 200-day MA is often used by investors to determine the long-term bullish or bearish trend.

CTNM Technical

CTNM Technical

Technical Sentiment

Overall Consensus

Technical Analysis Consensus

Moving Average Consensus

Technical Analysis for CTNM